Spyre Therapeutics (SYRE) Debt Ratio: 2023-2025
Historic Debt Ratio for Spyre Therapeutics (SYRE) over the last 3 years, with Sep 2025 value amounting to 0.02.
- Spyre Therapeutics' Debt Ratio fell 62.83% to 0.02 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02, marking a year-over-year decrease of 62.83%. This contributed to the annual value of 0.04 for FY2024, which is 913.70% up from last year.
- Per Spyre Therapeutics' latest filing, its Debt Ratio stood at 0.02 for Q3 2025, which was down 80.35% from 0.11 recorded in Q2 2025.
- In the past 5 years, Spyre Therapeutics' Debt Ratio registered a high of 0.67 during Q2 2023, and its lowest value of 0.00 during Q4 2023.
- Its 3-year average for Debt Ratio is 0.10, with a median of 0.04 in 2024.
- Its Debt Ratio has fluctuated over the past 5 years, first crashed by 99.10% in 2024, then surged by 1,736.21% in 2025.
- Quarterly analysis of 3 years shows Spyre Therapeutics' Debt Ratio stood at 0.00 in 2023, then skyrocketed by 913.70% to 0.04 in 2024, then crashed by 62.83% to 0.02 in 2025.
- Its last three reported values are 0.02 in Q3 2025, 0.11 for Q2 2025, and 0.08 during Q1 2025.